Average cost of drugs for extensively drug-resistant tuberculosis in Laos
Laos: Average cost of drugs for extensively drug-resistant tuberculosis was 1,250 constant 2022 US$ in 2024. ▬ Flat
Latest (2024)
1,250 constant 2022 US$
Change on year
unchanged
World rank
37th
of 56 countries
All-time high
1,250 constant 2022 US$
in 2018
All-time low
1,200 constant 2022 US$
in 2022
Years of data
7
2018–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Laos, 2018–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Laos recorded 1,250 constant 2022 US$ for average cost of drugs for extensively drug-resistant tuberculosis in 2024. That is the highest value across all 7 years on record.
That represents a change of unchanged over ten years.
Laos ranks 37th of 56 countries on this measure, in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Laos, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2018 | 1,250 constant 2022 US$ | — |
| 2019 | 1,250 constant 2022 US$ | +0.0% |
| 2020 | 1,250 constant 2022 US$ | +0.0% |
| 2021 | 1,250 constant 2022 US$ | +0.0% |
| 2022 | 1,200 constant 2022 US$ | -4.0% |
| 2023 | 1,250 constant 2022 US$ | +4.2% |
| 2024 | 1,250 constant 2022 US$ | +0.0% |
Laos compared with similar countries
- Laos's 1,250 constant 2022 US$ is below the median for lower middle income countries, which is 1,525 constant 2022 US$, 82% of the median. (24 countries reporting)
- Laos's 1,250 constant 2022 US$ is above the median for East Asia & Pacific, which is 1,194 constant 2022 US$, 1.0× the median. (8 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,250 constant 2022 US$ | 1,250 constant 2022 US$ | 1,250 constant 2022 US$ | 2 |
| 2020s | 1,240 constant 2022 US$ | 1,200 constant 2022 US$ | 1,250 constant 2022 US$ | 5 |
Countries ranked near Laos
More reference data data for Laos
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.6615 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.913 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 1.88 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.3021 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 1.88 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 2.22 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 3.96 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 5.07 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 12.95 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 1.64 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Laos?
- Average cost of drugs for extensively drug-resistant tuberculosis in Laos was 1,250 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Laos?
- The highest recorded value was 1,250 constant 2022 US$ in 2018.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Laos?
- The lowest recorded value was 1,200 constant 2022 US$ in 2022.
- How does Laos rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Laos ranks 37th out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Laos?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Laos data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.